Author:
Ballesteros Angel Luis,Fuster Daniel,Planas Ramon,Clotet Bonaventura,Tural Cristina
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference28 articles.
1. Manns MP, McHutchison JG, Gordon S et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet2001; 358: 958–65.
2. Fried M, Shiffman M, Reddy R et al. Peg-interferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. New Engl J Med2002; 347: 975–82.
3. Torriani FJ, Rodriguez-Torres M, Rockstroh JK et al. (APRICOT Study Group) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV patients. New Engl J Med2004; 351: 438–50.
4. Carrat F, Bani-Sadr F, Pol S et al. ANRS HC02-RIBAVIC study team. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA2004; 15: 292 (23), 2839–48.
5. Pérez-Olmeda M, Núñez M, Romero M et al. Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients. AIDS2003; 17: 1023–8.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献